| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Reneo Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 14,815 | 06 Jun 2023 | Direct | ||
| Kronos Bio, Inc. | Director | Stock Option (Right to Buy) | 0 | 20 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| KRON | Kronos Bio, Inc. | 20 Jun 2025 | 4 | $0 | 4 | Director | 20 Jun 2025, 16:15 |
| KRON | Kronos Bio, Inc. | 25 Jun 2024 | 1 | $0 | 4 | Director | 26 Jun 2024, 16:33 |
| KRON | Kronos Bio, Inc. | 22 Jun 2023 | 1 | $0 | 4 | Director | 26 Jun 2023, 16:12 |
| OKUR | Reneo Pharmaceuticals, Inc. | 06 Jun 2023 | 1 | $0 | 4 | Director | 08 Jun 2023, 18:17 |
| OKUR | Reneo Pharmaceuticals, Inc. | 02 Aug 2022 | 1 | $0 | 4 | Director | 02 Aug 2022, 19:16 |
| OKUR | Reneo Pharmaceuticals, Inc. | 02 Aug 2022 | 0 | $0 | 3 | Director | 02 Aug 2022, 19:08 |
| KRON | Kronos Bio, Inc. | 22 Jun 2022 | 1 | $0 | 4 | Director | 29 Jun 2022, 16:12 |
| KRON | Kronos Bio, Inc. | 11 Nov 2021 | 1 | $0 | 4 | Director | 15 Nov 2021, 12:45 |
| KRON | Kronos Bio, Inc. | 11 Nov 2021 | 0 | $0 | 3 | Director | 15 Nov 2021, 12:43 |